Rebuttal: Use of embolic protection devices in saphenous vein graft interventions: The ongoing challenge

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 1, 2014, Pages

  Badhey, Neeraj ^a   Banerjee, Subhash ^a   Brilakis, Emmanouil S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEVICE SAFETY; EMBOLIC PROTECTION DEVICE; HEART INFARCTION; HUMAN; LETTER; MEDICAL EDUCATION; MORTALITY; POSTOPERATIVE COMPLICATION; PROFESSIONAL KNOWLEDGE; RISK BENEFIT ANALYSIS; SAPHENOUS VEIN GRAFT; ADVERSE EFFECTS; CORONARY ARTERY BYPASS GRAFT; DEVICES; EMBOLISM; GRAFT OCCLUSION, VASCULAR; MALE; SAPHENOUS VEIN; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TRANSPLANTATION;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY BYPASS; EMBOLISM; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; SAPHENOUS VEIN; STENTS;

EID: 84903450365     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22801     Document Type: Letter

References (7)

1. Rao SV, Ou F-S, Wang TY, Roe MT, Brindis R, Rumsfeld JS, Peterson ED,. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: A report from the National Cardiovascular Data Registry. J Am Coll Cardiol Interv 2008; 1: 379-386.
2. ®. J Am Coll Cardiol Interv, in press.
3. Baim DS,. Percutaneous treatment of saphenous vein graft disease: The ongoing challenge. J Am Coll Cardiol 2003; 42: 1370-1372.
4. Banerjee S, Brilakis ES,. Embolic protection during saphenous vein graft interventions. J Invasive Cardiol 2009; 21: 415-417.
5. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Kent KM, Satler LF, Stone GW, Leon MB,. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999; 100: 2400-2405.
6. Mehta SK, Frutkin AD, Milford-Beland S, Klein LW, Shaw RE, Weintraub WS, Krone RJ, Anderson HV, Kutcher MA, Marso SP,. Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Am J Cardiol 2007; 100: 1114-1118.
7. Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L,. Saphenous vein graft stenting and major adverse cardiac events: A predictive model derived from a pooled analysis of 3958 patients. Circulation 2008; 117: 790-797.